deferoxamine has been researched along with 1-anilino-8-naphthalenesulfonate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Krüger, N; Schröter, W; Stubbe, P; Tillmann, W | 1 |
| Feng, M; Jin, C; Li, Y; Liu, XY; Tao, LD; Zhang, PJ; Zhou, B | 1 |
| Hashimoto, T; Higashida, K; Inoue, S; Nakai, N; Takeuchi, N | 1 |
3 other study(ies) available for deferoxamine and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
[Continuous subcutaneous deferoxamine infusions in thalassemia major. Improvement in glucose tolerance].
Topics: Adolescent; Adult; alpha-Amylases; Blood Glucose; Child; Child, Preschool; Deferoxamine; Diabetes Complications; Female; Hemosiderosis; Humans; Infusions, Parenteral; Injections, Subcutaneous; Lipase; Male; Thalassemia | 1986 |
Protective effects of deferoxamine mesylate preconditioning on pancreatic tissue in orthotopic liver autotransplantation in rats.
Topics: Amylases; Animals; Deferoxamine; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lipase; Liver Transplantation; Malondialdehyde; Microscopy; Pancreas; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2011 |
Iron deficiency attenuates catecholamine‑stimulated lipolysis via downregulation of lipolysis‑related proteins and glucose utilization in 3T3‑L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Catecholamines; Deferoxamine; Down-Regulation; Glucose; Iron; Iron Deficiencies; Isoproterenol; Lipase; Lipid Metabolism; Lipolysis; Mice; Obesity; Perilipin-1; Siderophores; Sterol Esterase | 2020 |